论文信息 - Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. - 字舞流文

Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

C. Boersma | M. Rozenbaum

[1] J. Berkhof,et al. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands. , 2009, Vaccine.

[2] J. Habbema,et al. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. , 2009, Journal of the National Cancer Institute.

[3] J. J. Tamminga,et al. Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands. , 2009, Vaccine.

[4] Mark Jit,et al. Economic evaluation of human papillomavirus vaccination in the United Kingdom , 2008, BMJ : British Medical Journal.

[5] M. Postma,et al. Need for differential discounting of costs and health effects in cost effectiveness analyses , 2005, BMJ : British Medical Journal.